Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination.
Sokal A, Bastard P, Chappert P, Barba-Spaeth G, Fourati S, Vanderberghe A, Lagouge-Roussey P, Meyts I, Gervais A, Bouvier-Alias M, Azzaoui I, Fernández I, de la Selle A, Zhang Q, Bizien L, Pellier I, Linglart A, Rothenbuhler A, Marcoux E, Anxionnat R, Cheikh N, Léger J, Amador-Borrero B, Fouyssac F, Menut V, Goffard JC, Storey C, Demily C, Mallebranche C, Troya J, Pujol A, Zins M, Tiberghien P, Gray PE, McNaughton P, Sullivan A, Peake J, Levy R, Languille L, Rodiguez-Gallego C, Boisson B, Gallien S, Neven B, Michel M, Godeau B, Abel L, Rey FA, Weill JC, Reynaud CA, Tangye SG, Casanova JL, Mahévas M. Sokal A, et al. Among authors: fourati s. J Exp Med. 2023 Jan 2;220(1):e20220258. doi: 10.1084/jem.20220258. Epub 2022 Nov 7. J Exp Med. 2023. PMID: 36342455 Free PMC article.
Procalcitonin to Reduce Antibiotic Exposure during Acute Chest Syndrome in Adult Patients with Sickle-Cell Disease.
Razazi K, Gendreau S, Cuquemelle E, Khellaf M, Guillaud C, Godeau B, Melica G, Moutereau S, Gomart C, Fourati S, De Prost N, Carteaux G, Brun-Buisson C, Bartolucci P, Habibi A, Mekontso Dessap A. Razazi K, et al. Among authors: fourati s. J Clin Med. 2020 Nov 19;9(11):3718. doi: 10.3390/jcm9113718. J Clin Med. 2020. PMID: 33228148 Free PMC article.
Performance of 22 Rapid Lateral Flow Tests for SARS-CoV-2 Antigen Detection and Influence of "Variants of Concern": Implications for Clinical Use.
Gourgeon A, Soulier A, Audureau É, Khouider S, Galbin A, Langlois C, Bouvier-Alias M, Rodriguez C, Chevaliez S, Pawlotsky JM, Fourati S. Gourgeon A, et al. Among authors: fourati s. Microbiol Spectr. 2022 Aug 31;10(4):e0115722. doi: 10.1128/spectrum.01157-22. Epub 2022 Jul 12. Microbiol Spectr. 2022. PMID: 35862982 Free PMC article.
SARS-CoV-2 Genomic Characteristics and Clinical Impact of SARS-CoV-2 Viral Diversity in Critically Ill COVID-19 Patients: A Prospective Multicenter Cohort Study.
Fourati S, Audureau E, Arrestier R, Marot S, Dubois C, Voiriot G, Luyt CE, Urbina T, Mayaux J, Roque-Afonso AM, Pham T, Landraud L, Visseaux B, Roux D, Bellaiche R, L'honneur AS, Ait Hamou Z, Brichler S, Gaudry S, Salmona M, Clere-Jehl R, Azoulay E, Morand-Joubert L, Marcelin AG, Chaix ML, Descamps D, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, de Prost N. Fourati S, et al. Viruses. 2022 Jul 13;14(7):1529. doi: 10.3390/v14071529. Viruses. 2022. PMID: 35891509 Free PMC article.
Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses.
Ahmed-Belkacem A, Redjoul R, Brillet R, Ahnou N, Leclerc M, López-Molina DS, Soulier A, Gourgeon A, Rodriguez C, Maury S, Pawlotsky JM, Fourati S. Ahmed-Belkacem A, et al. Among authors: fourati s. Viruses. 2022 Aug 30;14(9):1928. doi: 10.3390/v14091928. Viruses. 2022. PMID: 36146735 Free PMC article.
SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals.
Sokal A, Barba-Spaeth G, Hunault L, Fernández I, Broketa M, Meola A, Fourati S, Azzaoui I, Vandenberghe A, Lagouge-Roussey P, Broutin M, Roeser A, Bouvier-Alias M, Crickx E, Languille L, Fournier M, Michel M, Godeau B, Gallien S, Melica G, Nguyen Y, Canoui-Poitrine F, Pirenne F, Megret J, Pawlotsky JM, Fillatreau S, Reynaud CA, Weill JC, Rey FA, Bruhns P, Mahévas M, Chappert P. Sokal A, et al. Among authors: fourati s. Immunity. 2023 Sep 12;56(9):2137-2151.e7. doi: 10.1016/j.immuni.2023.07.007. Epub 2023 Aug 4. Immunity. 2023. PMID: 37543032
Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).
Softic L, Brillet R, Berry F, Ahnou N, Nevers Q, Morin-Dewaele M, Hamadat S, Bruscella P, Fourati S, Pawlotsky JM, Ahmed-Belkacem A. Softic L, et al. Among authors: fourati s. Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00876-20. doi: 10.1128/AAC.00876-20. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32376613 Free PMC article.
SARS-CoV-2 variants and mutational patterns: relationship with risk of ventilator-associated pneumonia in critically ill COVID-19 patients in the era of dexamethasone.
Razazi K, Martins Bexiga A, Arrestier R, Peiffer B, Voiriot G, Luyt CE, Urbina T, Mayaux J, Pham T, Roux D, Bellaiche R, AIt Hamou Z, Gaudry S, Azoulay E, Mekontso Dessap A, Rodriguez C, Pawlotsky JM, Fourati S, de Prost N. Razazi K, et al. Among authors: fourati s. Sci Rep. 2023 Apr 24;13(1):6658. doi: 10.1038/s41598-023-33639-5. Sci Rep. 2023. PMID: 37095145 Free PMC article.
217 results